rs1452851644

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001113525.2(ZNF276):​c.164G>C​(p.Gly55Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000888 in 1,238,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000092 ( 0 hom. )

Consequence

ZNF276
NM_001113525.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.251

Publications

0 publications found
Variant links:
Genes affected
ZNF276 (HGNC:23330): (zinc finger protein 276) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in kinetochore. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.057816386).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF276NM_001113525.2 linkc.164G>C p.Gly55Ala missense_variant Exon 1 of 11 ENST00000443381.7 NP_001106997.1 Q8N554-1I6L9I3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF276ENST00000443381.7 linkc.164G>C p.Gly55Ala missense_variant Exon 1 of 11 1 NM_001113525.2 ENSP00000415836.2 Q8N554-1

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
151870
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000921
AC:
10
AN:
1086218
Hom.:
0
Cov.:
31
AF XY:
0.00000776
AC XY:
4
AN XY:
515180
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22488
American (AMR)
AF:
0.00
AC:
0
AN:
8030
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14044
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25610
South Asian (SAS)
AF:
0.00
AC:
0
AN:
24010
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21894
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2898
European-Non Finnish (NFE)
AF:
0.0000108
AC:
10
AN:
923760
Other (OTH)
AF:
0.00
AC:
0
AN:
43484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
151870
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
74208
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41404
American (AMR)
AF:
0.00
AC:
0
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10486
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67934
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 23, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.164G>C (p.G55A) alteration is located in exon 1 (coding exon 1) of the ZNF276 gene. This alteration results from a G to C substitution at nucleotide position 164, causing the glycine (G) at amino acid position 55 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
6.2
DANN
Benign
0.37
DEOGEN2
Benign
0.048
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.44
T
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.058
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.25
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
0.0
N
REVEL
Benign
0.0090
Sift
Benign
0.30
T
Sift4G
Benign
0.66
T
Polyphen
0.0020
B
Vest4
0.069
MutPred
0.15
Gain of MoRF binding (P = 0.1239);
MVP
0.014
MPC
0.073
ClinPred
0.052
T
GERP RS
-0.75
PromoterAI
0.0016
Neutral
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.9
Varity_R
0.037
gMVP
0.070
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1452851644; hg19: chr16-89788212; API